Propanc Biopharma raises ~$180k via convertible notes and board loan; conversion at deep discounts

Propanc Biopharma, Inc.

$55k face convertible note issued at $50k (original issue discount) to GS Capital Partners; conversion price $5.00, drops to $2.50 if stock below $4 for 5 days.
$79.2k convertible note issued with 15% one-time interest; conversion at 65% of lowest trading price after default (35% discount).
$63k AUD loan from board member at 12% interest, due June 30, 2025; all proceeds for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.